Axios Future of Health Care
The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.
When Payers Become Producers: Inside the PBM Private-Labeling Trend
The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.
House Energy and Commerce Subcommittee Holds Hearing on 340B Drug Pricing Program and Legislation
The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.
Medicare negotiated drug prices for the first time. Here’s what it got
The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.
Medicare Drug Price Negotiation Program: Negotiated Prices for Initial Price Applicability Year 2026
The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.
Mark Cuban wants to keep shaking up healthcare. Here’s Cost Plus Drug’s next move
The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.
To lower prescription drug costs, states head to the courthouse
The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.
Detecting Cancer Early Saves Lives. So Why Aren’t We Doing It?
The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.
Prior authorization bottlenecks patient care, critics say
The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.
Hot Summer Threatens Efficacy of Mail-Order Medications
The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.
